Surprisingly, however, individuals with metabolic disorders such as obesity, T2DM and fatty liver have high levels of FGF21 and respond poorly to exogenous FGF21, this phenomenon was defined as FGF21 resistance. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.